BRIEF-Tevogen Bio Announces Unique T Cell Vaccine Under Development & Files Patent With USPTO

Reuters
10 Mar
Tevogen Bio Holdings0.93%Post-market

March 10 (Reuters) - Tevogen Bio Holdings Inc TVGN.O:

  • TEVOGEN BIO ANNOUNCES UNIQUE T CELL VACCINE UNDER DEVELOPMENT AND FILES PATENT WITH THE USPTO

Source text: ID:nGNX41pdch

Further company coverage: TVGN.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

no data

No relevant data is available

If the download button clicks without skipping, click on the top right menu and select "Open in Browser."